|
1
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2012.
View Article : Google Scholar
|
|
3
|
Hamada T, Yasunaga H, Nakai Y, Isayama H,
Horiguchi H, Matsuda S, Fushimi K and Koike K: Severe bleeding and
perforation are rare complications of endoscopic ultrasound-guided
fine needle aspiration for pancreatic masses: An analysis of 3,090
patients from 212 hospitals. Gut Liver. 8:215–218. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Katanuma A, Maguchi H, Yane K, Hashigo S,
Kin T, Kaneko M, Kato S, Kato R, Harada R, Osanai M, et al: Factors
predictive of adverse events associated with endoscopic
ultrasound-guided fine needle aspiration of pancreatic solid
lesions. Dig Dis Sci. 58:2093–2099. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kato K, Kamada H, Fujimori T, Aritomo Y,
Ono M and Masaki T: Molecular biologic approach to the diagnosis of
pancreatic carcinoma using specimens obtained by EUS-guided fine
needle aspiration. Gastroenterol Res Pract. 2012:2435242012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gillis A, Cipollone I, Cousins G and
Conlon K: Does EUS-FNA molecular analysis carry additional value
when compared to cytology in the diagnosis of pancreatic cystic
neoplasm? A systematic review. HPB (Oxford). 17:377–386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
de Biase D, Visani M, Baccarini P,
Polifemo AM, Maimone A, Fornelli A, Giuliani A, Zanini N, Fabbri C,
Pession A and Tallini G: Next generation sequencing improves the
accuracy of KRAS mutation analysis in endoscopic ultrasound fine
needle aspiration pancreatic lesions. PLoS One. 9:e876512014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kubota Y, Kawakami H, Natsuizaka M,
Kawakubo K, Marukawa K, Kudo T, Abe Y, Kubo K, Kuwatani M, Hatanaka
Y, et al: CTNNB1 mutational analysis of solid-pseudopapillary
neoplasms of the pancreas using endoscopic ultrasound-guided
fine-needle aspiration and next-generation deep sequencing. J
Gastroenterol. 50:203–210. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bryant KL, Mancias JD, Kimmelman AC and
Der CJ: KRAS: Feeding pancreatic cancer proliferation. Trends
Biochem Sci. 39:91–100. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Biankin AV, Waddell N, Kassahn KS, Gingras
MC, Muthuswamy LB, Johns AL, Miller DK, Wilson PJ, Patch AM, Wu J,
et al: Pancreatic cancer genomes reveal aberrations in axon
guidance pathway genes. Nature. 491:399–405. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Collins MA, Bednar F, Zhang Y, Brisset JC,
Galbán S, Galbán CJ, Rakshit S, Flannagan KS, Adsay NV and di
Magliano M Pasca: Oncogenic Kras is required for both the
initiation and maintenance of pancreatic cancer in mice. J Clin
Invest. 122:639–653. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ryan DP, Hong TS and Bardeesy N:
Pancreatic adenocarcinoma. N Engl J Med. 371:1039–1049. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jeong J, Park YN, Park JS, Yoon DS, Chi HS
and Kim BR: Clinical significance of p16 protein expression loss
and aberrant p53 protein expression in pancreatic cancer. Yonsei
Med J. 46:519–525. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bardeesy N, Cheng KH, Berger JH, Chu GC,
Pahler J, Olson P, Hezel AF, Horner J, Lauwers GY, Hanahan D and
DePinho RA: Smad4 is dispensable for normal pancreas development
yet critical in progression and tumor biology of pancreas cancer.
Genes Dev. 20:3130–3146. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Waddell N, Pajic M, Patch AM, Chang DK,
Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K, et al:
Whole genomes redefine the mutational landscape of pancreatic
cancer. Nature. 518:495–501. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Young G, Wang K, He J, Otto G, Hawryluk M,
Zwirco Z, Brennan T, Nahas M, Donahue A, Yelensky R, et al:
Clinical next-generation sequencing successfully applied to
fine-needle aspirations of pulmonary and pancreatic neoplasms.
Cancer Cytopathol. 121:688–694. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liang WS, Craig DW, Carpten J, Borad MJ,
Demeure MJ, Weiss GJ, Izatt T, Sinari S, Christoforides A, Aldrich
J, et al: Genome-wide characterization of pancreatic adenocarcinoma
patients using next generation sequencing. PLoS One. 7:e431922012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ab Mutalib NS, Syafruddin SE, Md Zain RR,
Dali AZ Mohd, Yunos RI Mohd, Saidin S, Jamal R and Mokhtar NM:
Molecular characterization of serous ovarian carcinoma using a
multigene next generation sequencing cancer panel approach. BMC Res
Notes. 7:8052014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rothé F, Laes JF, Lambrechts D, Smeets D,
Vincent D, Maetens M, Fumagalli D, Michiels S, Drisis S, Moerman C,
et al: Plasma circulating tumor DNA as an alternative to metastatic
biopsies for mutational analysis in breast cancer. Ann Oncol.
25:1959–1965. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cao YY, Qu YJ, Song F, Zhang T, Bai JL,
Jin YW and Wang H: Fast clinical molecular diagnosis of
hyperphenylalaninemia using next-generation sequencing-based on a
custom AmpliSeq™ panel and Ion Torrent PGM sequencing. Mol Genet
Metab. 113:261–266. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gonzalez-Perez A, Deu-Pons J and
Lopez-Bigas N: Improving the prediction of the functional impact of
cancer mutations by baseline tolerance transformation. Genome Med.
4:892012. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bournet B, Selves J, Grand D, Danjoux M,
Hanoun N, Cordelier P and Buscail L: Endoscopic ultrasound-guided
fine-needle aspiration biopsy coupled with a KRAS mutation assay
using allelic discrimination improves the diagnosis of pancreatic
cancer. J Clin Gastroenterol. 49:50–56. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu QY, Chang MN, Lei JX, Koukiekolo R,
Smith B, Zhang D and Ghribi O: Identification of microRNAs involved
in Alzheimer's progression using a rabbit model of the disease. Am
J Neurodegener Dis. 3:33–44. 2014.PubMed/NCBI
|
|
24
|
Ramesh J and Varadarajulu S: How can we
get the best results with endoscopic ultrasound-guided fine needle
aspiration? Clin Endosc. 45:132–137. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lunardi S, Muschel RJ and Brunner TB: The
stromal compartments in pancreatic cancer: Are there any
therapeutic targets? Cancer Lett. 343:147–155. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fuccio L, Hassan C, Laterza L, Correale L,
Pagano N, Bocus P, Fabbri C, Maimone A, Cennamo V, Repici A, et al:
The role of K-ras gene mutation analysis in EUS-guided FNA cytology
specimens for the differential diagnosis of pancreatic solid
masses: A meta-analysis of prospective studies. Gastrointest
Endosc. 78:596–608. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yachida S, White CM, Naito Y, Zhong Y,
Brosnan JA, Macgregor-Das AM, Morgan RA, Saunders T, Laheru DA,
Herman JM, et al: Clinical significance of the genetic landscape of
pancreatic cancer and implications for identification of potential
long-term survivors. Clin Cancer Res. 18:6339–6347. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Blackford A, Serrano OK, Wolfgang CL,
Parmigiani G, Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ,
Eshleman JR, et al: SMAD4 gene mutations are associated with poor
prognosis in pancreatic cancer. Clin Cancer Res. 15:4674–4679.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Navas C, Hernández-Porras I, Schuhmacher
AJ, Sibilia M, Guerra C and Barbacid M: EGF receptor signaling is
essential for k-ras oncogene-driven pancreatic ductal
adenocarcinoma. Cancer Cell. 22:318–330. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jancík S, Drábek J, Radzioch D and Hajdúch
M: Clinical relevance of KRAS in human cancers. J Biomed
Biotechnol. 2010:1509602010. View Article : Google Scholar : PubMed/NCBI
|
